A
Description
Multinational pharmaceutical company headquartered in London (formerly Concordia Healthcare, renamed in 2018). Specialized in the commercialization of specialty, hospital, and rare disease medicines. Commercial presence in over 90 countries, direct presence in 20+. Therapeutic areas: hepatology, gastroenterology, anti-infectives, critical care, endocrinology, and rare diseases.